AG18

CAS No. 118409-57-7

AG18( RG-50810 | RG-50858 | TX 825 | Tyrphostin 23 | Tyrphostin AG-18 )

Catalog No. M10624 CAS No. 118409-57-7

AG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 34 In Stock
10MG 51 In Stock
25MG 118 In Stock
50MG 219 In Stock
100MG 330 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AG18
  • Note
    Research use only, not for human use.
  • Brief Description
    AG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
  • Description
    AG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
  • In Vitro
    10 μM tyrphostin 23 causes significant inhibition of the cell proliferation caused by 1 nM and 1μM ghrelin. Tyrphostin 23 (T23) is a well-known inhibitor of protein tyrosine kinases and has been considered as potential anti-cancer drug. T23 is reported to acutely stimulate the glycolytic flux in primary cultured astrocytes. Tyrphostin 23 stimulates glycolytic flux in cultured astrocytes. Mitochondrial metabolism of brain astrocytes is accelerated by Tyrphostin 23 exposure.
  • In Vivo
    ——
  • Synonyms
    RG-50810 | RG-50858 | TX 825 | Tyrphostin 23 | Tyrphostin AG-18
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    118409-57-7
  • Formula Weight
    186.17
  • Molecular Formula
    C10H6N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 37 mg/mL (198.74 mM); DMSO: 37 mg/mL (198.74 mM)
  • SMILES
    N#C/C(C#N)=C/C1=CC=C(O)C(O)=C1
  • Chemical Name
    2-[(3,4-dihydroxyphenyl)methylene]-propanedinitrile

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gazit A, et al. J Med Chem, 1989, 32(10), 2344-2352.
molnova catalog
related products
  • Selatinib

    Selatinib is an orally active and potent dual inhibitor of EGFR and ErbB2 with anticancer activity that inhibits the growth of NCI-N87 tumor cells.

  • Pelitinib

    A potent, selective, orally active, irreversible inhibitor of EGFR with IC50 of 80 nM.

  • AST-1306

    AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, also effective in mutation EGFR T790M/L858R.